The objective of the Institute for Translational Neuroscience is to develop novel therapeutics for drug and alcohol use disorders, PTSD, stress, anxiety, impulsivity, and depression
Our program goals include the identification of medications to stabilize or mitigate alcohol and substance use disorders, both when presenting with and without comorbid psychological and neurological conditions.